http://seekingalpha.com/article/256100-pending-fda-approval-means-mannkind-is-down-but-it-s-not-out?source=yahooPartnership discussions are underway. News of a partnership could move the share price to the $10.00 range.Cheap shares are being accumulated here.Due diligence.
Stong move up last two days. Bottom appears to be in place.
Market down almost 200 points and Mannkind is moving higher. Seems as though an up trend is in place.
Mannkind's share price will start moving higher as the time frame for a partnership announcement approaches.Mannkind's depressed share price could attract an unsolicited bid at any time.GLTA
Mannkind's current share price substantially undervalues its drug pipeline.Partnership or buyout offer could move it substantially higher at any time.
Overdue for a move higher. At or near the bottom here.